Published in Eur J Immunol on March 01, 1989
Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med (1995) 2.05
Suppressive effect of antibody on processing of T cell epitopes. J Exp Med (1993) 1.48
Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc Natl Acad Sci U S A (2001) 1.39
Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice. J Virol (1991) 1.24
Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J Virol (1993) 1.19
Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection. J Virol (1995) 1.19
Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective. J Virol (1995) 1.17
T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II. Infect Immun (1995) 1.16
Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol (1992) 0.98
N-terminal amino acid sequence identity between a major allergen of Ascaris lumbricoides and Ascaris suum, and MHC-restricted IgE responses to it. Immunology (1990) 0.97
Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin. J Virol (1990) 0.96
Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones. J Virol (1994) 0.94
Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones. J Virol (1992) 0.90
Focused antibody response to influenza linked to antigenic drift. J Clin Invest (2015) 0.89
T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus. J Virol (1991) 0.88
Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma? Immunology (2007) 0.87
MHC (RT1) restriction of the antibody repertoire to infection with the nematode Nippostrongylus brasiliensis in the rat. Immunology (1990) 0.84
Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides. J Virol (1993) 0.83
Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies. J Immunol (2014) 0.83
Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology. Immunology (1996) 0.82
Predominant recognition of species-specific determinants of the GroES homologues from Mycobacterium leprae and M. tuberculosis. Immunology (1998) 0.81
An influenza haemagglutinin-specific IgG enhances class I MHC-restricted CTL killing in vitro. Immunology (1991) 0.79
Single amino acid residues in a synthetic peptide of influenza haemagglutinin, HA 1 177-199, distinguish I-Ad- and I-Ed-restricted T-cell epitopes. Immunology (1990) 0.79
Recognition of higher order patterns in proteins: immunologic kernels. PLoS One (2013) 0.78
Patterns of predicted T-cell epitopes associated with antigenic drift in influenza H3N2 hemagglutinin. PLoS One (2011) 0.78
Defects in antigen presentation of mutant influenza haemagglutinins are reversed by mutations in the MHC class II molecule. EMBO J (1990) 0.77
H-2 (I-A) control of the antibody repertoire to secreted antigens of Trichinella spiralis in infection and its relevance to resistance and susceptibility. Immunology (1991) 0.76
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature (1988) 8.32
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (2004) 7.74
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
The molecular basis of the specific anti-influenza action of amantadine. EMBO J (1985) 7.08
X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc Natl Acad Sci U S A (2001) 5.92
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Crystalline antigen from the influenza virus envelope. Nat New Biol (1972) 5.77
Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell (1985) 4.84
Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts. Nucleic Acids Res (1978) 4.83
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA (1991) 4.49
A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A (1984) 4.37
Cytotoxic T cells to type A influenza virus; viral hemagglutinin induces A-strain specificity while infected cells confer cross-reactive cytotoxicity. Eur J Immunol (1977) 4.05
Transcription of the influenza virus genome. Virology (1977) 4.02
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A (1999) 3.90
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
Studies on the in vitro transcription of reovirus RNA catalyzed by reovirus cores. Virology (1969) 3.79
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat Struct Biol (1999) 3.72
Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell (1998) 3.69
Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature (1977) 3.67
Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. J Gen Virol (1983) 3.43
Evidence from detrital zircons for the existence of continental crust and oceans on the Earth 4.4 Gyr ago. Nature (2001) 3.30
Structural basis for membrane fusion by enveloped viruses. Mol Membr Biol (1999) 3.26
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry (1992) 3.03
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (1995) 2.92
Studies on the primary structure of the influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1975) 2.88
The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross-reactive cytotoxic T cells. J Exp Med (1984) 2.81
Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. Virology (1989) 2.74
Polypeptide synthesis in influenza virus-infected cells. Virology (1972) 2.70
H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology (2004) 2.67
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61
Refinement of the influenza virus hemagglutinin by simulated annealing. J Mol Biol (1990) 2.61
An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology (2002) 2.56
Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature (1995) 2.55
Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology (1997) 2.51
On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. J Gen Virol (1978) 2.50
Interferon action--sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. Nature (1981) 2.49
A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol (1999) 2.47
Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell (1992) 2.47
The polypeptides of adenovirus-infected cells. J Gen Virol (1972) 2.43
Structural studies on human erythrocyte glycoproteins. Alkali-labile oligosaccharides. J Biol Chem (1969) 2.43
Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol (1993) 2.42
Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature (1998) 2.41
Characterization of influenza virus RNA complete transcripts. Virology (1982) 2.31
Influenza virus messenger RNAs are incomplete transcripts of the genome RNAs. Nucleic Acids Res (1977) 2.26
A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci U S A (1995) 2.24
Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. Biochemistry (1989) 2.24
The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J (1996) 2.21
Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J Gen Virol (1988) 2.21
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus. J Virol (1974) 2.19
Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology (1986) 2.13
Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother (1986) 2.04
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A (2001) 2.04
The occurrence of autoantibodies in infectious mononucleosis. Clin Exp Immunol (1974) 2.00
Structural evidence for recognition of a single epitope by two distinct antibodies. Proteins (2000) 1.99
Antibodies to membrane antigen(s) common to thymocytes and a subpopulation of lymphocytes in infectious-mononucleosis sera. Lancet (1972) 1.98
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J Virol (1995) 1.96
Electric power, pineal function, and the risk of breast cancer. FASEB J (1992) 1.95
Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology (1998) 1.95
Evidence from studies with a cross-linking reagent that the haemagglutinin of influenza virus is a trimer. Virology (1977) 1.93
Host-mediated selection of influenza virus receptor variants. Sialic acid-alpha 2,6Gal-specific clones of A/duck/Ukraine/1/63 revert to sialic acid-alpha 2,3Gal-specific wild type in ovo. J Biol Chem (1985) 1.91
Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Proc Natl Acad Sci U S A (1983) 1.88
Antigen distortion allows influenza virus to escape neutralization. Nat Struct Biol (1998) 1.88
Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology (2000) 1.87
Electron microscopy of the low pH structure of influenza virus haemagglutinin. EMBO J (1986) 1.87
rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J Virol (1983) 1.81
Mechanism of neutralization of influenza virus infectivity by antibodies. Virology (2002) 1.80
Amantadine selection of a mutant influenza virus containing an acid-stable hemagglutinin glycoprotein: evidence for virus-specific regulation of the pH of glycoprotein transport vesicles. Proc Natl Acad Sci U S A (1991) 1.79
Studies of influenza haemagglutinin-mediated membrane fusion. Virology (1986) 1.78
Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol (1991) 1.76
Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J (1995) 1.74
Estimations of the molecular weight of the influenza virus genome. J Gen Virol (1971) 1.74
Blood volume determination in the mouse. J Physiol (1973) 1.72
Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin. Nature (1984) 1.72
Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J Virol (1987) 1.70
Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer (2000) 1.70
Membrane fusion by peptide analogues of influenza virus haemagglutinin. J Gen Virol (1988) 1.69
Avian and human receptor binding by hemagglutinins of influenza A viruses. Glycoconj J (2006) 1.66
Comparative analyses of the specificities of anti-influenza hemagglutinin antibodies in human sera. J Virol (1986) 1.65
Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities. Virology (1984) 1.64
A prospective study of serum antibody and protection against smallpox. Am J Trop Med Hyg (1972) 1.62
Nucleotide sequences at the terminal of La Crosse virus RNAs. Nucleic Acids Res (1980) 1.61
The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc Natl Acad Sci U S A (1998) 1.58
Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev (1996) 1.57
Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci (1995) 1.57
Epidemiology of smallpox in West Pakistan. I. Acquired immunity and the distribution of disease. Am J Epidemiol (1972) 1.57
The matrix protein gene determines amantadine-sensitivity of influenza viruses. J Gen Virol (1979) 1.54
Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst (1980) 1.54
Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties. Virology (1991) 1.50
Proteins synthesized in chick cells following infection with Semliki Forest virus. J Gen Virol (1968) 1.50
Differences in the sex ratio of laryngeal cancer incidence rates by anatomic subsite. J Clin Epidemiol (1989) 1.50
The preparation and properties of adenovirus cores. J Gen Virol (1971) 1.49